355 related articles for article (PubMed ID: 26592511)
1. Toll-like receptors: potential targets for lupus treatment.
Wu YW; Tang W; Zuo JP
Acta Pharmacol Sin; 2015 Dec; 36(12):1395-407. PubMed ID: 26592511
[TBL] [Abstract][Full Text] [Related]
2. Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.
Lenert P
Clin Exp Immunol; 2010 Aug; 161(2):208-22. PubMed ID: 20456414
[TBL] [Abstract][Full Text] [Related]
3. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
Sun L; Liu W; Zhang LJ
J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
[TBL] [Abstract][Full Text] [Related]
4. Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus.
Baek WY; Choi YS; Lee SW; Son IO; Jeon KW; Choi SD; Suh CH
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884569
[TBL] [Abstract][Full Text] [Related]
5. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
[TBL] [Abstract][Full Text] [Related]
6. The role of toll-like receptors in systemic lupus erythematosus.
Rahman AH; Eisenberg RA
Springer Semin Immunopathol; 2006 Oct; 28(2):131-43. PubMed ID: 17047954
[TBL] [Abstract][Full Text] [Related]
7. Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus.
Ma K; Li J; Fang Y; Lu L
Int J Mol Sci; 2015 Jun; 16(6):13084-105. PubMed ID: 26068236
[TBL] [Abstract][Full Text] [Related]
8. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
Chyuan IT; Tzeng HT; Chen JY
Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females.
Laska MJ; Troldborg A; Hansen B; Stengaard-Pedersen K; Junker P; Nexø BA; Voss A
Rheumatology (Oxford); 2014 Jan; 53(1):48-55. PubMed ID: 24064706
[TBL] [Abstract][Full Text] [Related]
10. Development of TLR inhibitors for the treatment of autoimmune diseases.
Barrat FJ; Coffman RL
Immunol Rev; 2008 Jun; 223():271-83. PubMed ID: 18613842
[TBL] [Abstract][Full Text] [Related]
11. A Novel Small-Molecule Inhibitor of Endosomal TLRs Reduces Inflammation and Alleviates Autoimmune Disease Symptoms in Murine Models.
Patra MC; Achek A; Kim GY; Panneerselvam S; Shin HJ; Baek WY; Lee WH; Sung J; Jeong U; Cho EY; Kim W; Kim E; Suh CH; Choi S
Cells; 2020 Jul; 9(7):. PubMed ID: 32660060
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 Alters the Expression of Toll-like Receptors in Peripheral Blood Mononuclear Cells of Patients With Systemic Lupus Erythematosus.
Yazdanpanah E; Mahmoudi M; Sahebari M; Rezaieyazdi Z; Esmaeili SA; Tabasi N; Jaberi S; Sahebkar A; Rastin M
J Cell Biochem; 2017 Dec; 118(12):4831-4835. PubMed ID: 28544067
[TBL] [Abstract][Full Text] [Related]
13. Targeting Toll-like receptors for treatment of SLE.
Horton CG; Pan ZJ; Farris AD
Mediators Inflamm; 2010; 2010():. PubMed ID: 20886024
[TBL] [Abstract][Full Text] [Related]
14. Targeting Toll-like receptors: emerging therapeutics?
Hennessy EJ; Parker AE; O'Neill LA
Nat Rev Drug Discov; 2010 Apr; 9(4):293-307. PubMed ID: 20380038
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors pathways implication in common autoimmune diseases and therapeutic perspectives.
Alexoudi I; Kapsimali V; Vaiopoulos A; Kanakis M; Vaiopoulos G
G Ital Dermatol Venereol; 2015 Apr; 150(2):255-60. PubMed ID: 25876147
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors in systemic lupus erythematosus: potential targets for therapeutic intervention.
Horton CG; Farris AD
Curr Allergy Asthma Rep; 2012 Feb; 12(1):1-7. PubMed ID: 22086298
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic targets in systemic lupus.
Sifuentes Giraldo WA; García Villanueva MJ; Boteanu AL; Lois Iglesias A; Zea Mendoza AC
Reumatol Clin; 2012; 8(4):201-7. PubMed ID: 22483661
[TBL] [Abstract][Full Text] [Related]
18. Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery.
Li Y; Wu T
Expert Opin Drug Discov; 2018 Aug; 13(8):765-777. PubMed ID: 29863906
[TBL] [Abstract][Full Text] [Related]
19. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus.
Richez C; Blanco P; Rifkin I; Moreau JF; Schaeverbeke T
Joint Bone Spine; 2011 Mar; 78(2):124-30. PubMed ID: 20961794
[TBL] [Abstract][Full Text] [Related]
20. [TLR function in autoimmunological processes].
Klonowska-Szymczyk A; Wolska A; Robak E
Postepy Hig Med Dosw (Online); 2009 Jul; 63():331-9. PubMed ID: 19644149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
